AI assistant

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

TherapeuticsMD, Inc. Director's Dealing 2005

Jan 13, 2005

35134_dirs_2005-01-13_17d0dd5f-6e7e-4221-b756-7b0158ef13d4.zip

Director's Dealing

Open in viewer

Opens in your device viewer

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: CROFF ENTERPRISES INC (coff)
CIK: 0000025743
Period of Report: 2005-01-05

Reporting Person: JENSEN GERALD L (Director, President, 10% Owner)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2005-01-05	Croff Enterprises, Inc.	P	1500	$1.575	Acquired	246988	Direct
2005-01-05	Croff Enterprises, Inc.	D	1500	$1.575	Disposed	246988	Direct
2005-01-12	Croff Enterprises, Inc.	P	500	$1.5	Acquired	246988	Direct
2005-01-12	Croff Enterprises, Inc.	D	500	$1.5	Acquired	246988	Direct

Footnotes

F1: Mr. Jensen acquired these shares as an agent on behalf of Croff Enterprises, Inc. Croff Enterprises, Inc. purchased these shares for its treasury.